3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Primary Malignant Peripheral Nerve Sheath Tumors
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Oligodendroglioma
1
Myelodysplastic Syndromes
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Leukemia, Myelomonocytic, Chronic
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
GATA2 Deficiency
1
Brain Neoplasms
1
Astrocytoma
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
taxane
1
radium Ra 223 dichloride
1
pertuzumab
1
X-Rays
1
Trastuzumab
1
Taxoids
1
Taxes
1
Steroids
1
Radiotherapy
1
Radiosurgery
1
Radiation
1
Photons
1
Paclitaxel
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Mastectomy, Simple
1
Mastectomy, Segmental
1
Hormones
1
High-Energy Shock Waves
1
Cyclin-Dependent Kinase Inhibitor p18
1
Cyclin-Dependent Kinase Inhibitor p16
1
CT-P6
1
Biopsy
1
Ado-Trastuzumab Emtansine
1
2C4 antibody
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anatomic Stage IV Breast Cancer AJCC v8
×
Vorinostat
×
30 days
×
Clear all
No trials found.